These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22836221)

  • 1. Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.
    Martín-Salces M; Jiménez-Yuste V; Álvarez-Román MT; Rivas-Pollmar I; Rodríguez de la Rúa A
    Thromb Haemost; 2012 Oct; 108(4):796-8. PubMed ID: 22836221
    [No Abstract]   [Full Text] [Related]  

  • 2. Conservative management of a haemorrhagic adnexal cyst in a patient with Type 3 von Willebrand Disease.
    Boama V; Haynes S
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):236-7. PubMed ID: 21752528
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy in type 2B VWD: a case series.
    Ranger A; Manning RA; Lyall H; Laffan MA; Millar CM
    Haemophilia; 2012 May; 18(3):406-12. PubMed ID: 22077376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of von Willebrand disease type 3 during pregnancy - 2 cases reports.
    Inocêncio G; Braga A; Azevedo S; Buchner G
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2857-9. PubMed ID: 24254552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
    Kessler CM; Friedman K; Schwartz BA; Gill JC; Powell JS;
    Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
    Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
    Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding management of uterine conization using a pasteurized FVIII/VWF Concentrate in a woman affected by type 2A von willebrand disease.
    Lapecorella M; Napoletano M; Mariani G; Mascaretti G; Colageo E
    Clin Appl Thromb Hemost; 2009; 15(2):245-6. PubMed ID: 18160560
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregnancy in women with different types of von Willebrand disease.
    Conti M; Mari D; Conti E; Muggiasca ML; Mannucci PM
    Obstet Gynecol; 1986 Aug; 68(2):282-5. PubMed ID: 3090493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of patients with Type 2B von Willebrand's disease during delivery and puerperium].
    Güth U; Tsakiris DA; Reber A; Holzgreve W; Hösli I
    Z Geburtshilfe Neonatol; 2002; 206(4):151-5. PubMed ID: 12198592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pregnancy in type 3 von Willebrand disease with alloantibodies.
    Scott M; Hay CRM; Elkhalifa S; Tower C; Cocker M; Thachil J
    Br J Haematol; 2018 Aug; 182(3):440-442. PubMed ID: 28699647
    [No Abstract]   [Full Text] [Related]  

  • 15. [Childbirth without fear in case of Von Willebrand's disease].
    Cornuz J; Knecht H; Delaloye JF; Bossart H; Bachmann F
    Schweiz Med Wochenschr; 1993 Jan; 123(3):76-9. PubMed ID: 8426951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
    Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
    Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hodgkin's lymphoma in a patient with type III von Willebrand's disease.
    Warad D; Kumar R; Rodriguez V
    Haemophilia; 2012 Sep; 18(5):e378-9. PubMed ID: 22757977
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics od preoperative, intraoperative and postoperative care of gynecological patients with von Willebrand's disease].
    Malinov OA; Likhacheva EA
    Akush Ginekol (Mosk); 1991 Oct; (10):67-71. PubMed ID: 1789332
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.
    Groeneveld DJ; van Bekkum T; Cheung KL; Dirven RJ; Castaman G; Reitsma PH; van Vlijmen B; Eikenboom J
    J Thromb Haemost; 2015 Apr; 13(4):592-600. PubMed ID: 25650553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.